Harvard Bioscience (HBIO) Net Margin Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -142.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -916.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -160.00 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -40.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 365.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -597.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -1,595.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 132.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -229.00 |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 21,448.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,448.00 |
| Dec 31, 2025 | -1,440.00 |
| Sep 30, 2025 | 1,588.00 |
| Jun 30, 2025 | 131.00 |
| Mar 31, 2025 | -21,183.00 |
| Dec 31, 2024 | 572.00 |
| Sep 30, 2024 | -1,697.00 |
| Jun 30, 2024 | -906.00 |
| Mar 31, 2024 | -2,122.00 |
| Dec 31, 2023 | 196.00 |
| Sep 30, 2023 | 776.00 |
| Jun 30, 2023 | -1,174.00 |
| Mar 31, 2023 | 2,611.00 |
| Dec 31, 2022 | -940.00 |
| Sep 30, 2022 | -1,207.00 |
| Jun 30, 2022 | 982.00 |
| Mar 31, 2022 | -2,156.00 |
| Dec 31, 2021 | 407.00 |
| Sep 30, 2021 | 407.00 |
| Jun 30, 2021 | 530.00 |